Industry News
Medical Device Industry News
AI Detection of STEMI Equivalents: A Breakthrough in Emergency Cardiac Care
While ST-segment elevation myocardial infarction (STEMI) has traditionally been the cornerstone of heart attack diagnosis, a growing body of evidence highlights the importance of STEMI equivalents - ECG patterns indicating cardiac events that do not
Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories
Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and
Bracco Imaging S.A. and Arrayus Technologies Announce Agreement to Enhance Drug Delivery for Pancreatic Cancer Treatment Using Focused Ultrasound and Microbubble Technology
Under the terms of the agreement, Bracco Imaging will supply Arrayus with microbubbles for use in the development and commercialization of its focused ultrasound platform for pancreatic cancer.
Which Bariatric Surgery is the Most Effective?
Bariatric Surgery: Obesity, characterized by excessive body fat accumulation, poses severe health risks such as heart disease, diabetes, and hypertension. It often results from genetic, behavioral, and environmental factors, which can lead to the need
Lonza Launches Innovaform™ Accelerator, the New Innovation and Formulation Center in Colmar (FR)
Christian Seufert, President, Capsules & Health Ingredients, Lonza, commented: “The Innovaform™ Innovation and Formulation Accelerator represents a unique solution for drug developers seeking to solve complex dosage form and delivery challenges through innovation.
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
"The approval from the MIEC, coming closely on the heels of our two ethics committee approvals in Australia, to conduct this early feasibility study, is another important step in our plan to evaluate use of
Revolo Biotherapeutics Announces New Preclinical Data Further Validating Atopic Dermatitis as a Target Indication for ‘1104
Revolo Biotherapeutics notes the data reinforces the broad clinical applicability of ‘1104, through a novel upstream mechanism of action (MOA), demonstrating its impact across skin disease measures and a wide range of inflammatory cytokines and
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
Compounded GLP-1 injections are fulfilled and shipped from Hims & Hers' affiliated pharmacies. The treatments customers receive from Hims & Hers will always come from a state-licensed, FDA-regulated facility. The company maintains high standards of
NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases
Under the terms of the agreement, Novo Nordisk and NanoVation Therapeutics will collaborate on two lead programs to develop base-editing therapies for certain rare genetic diseases, and up to five additional future targets for cardiometabolic
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
Tivic Health reports this clinical research collaboration with Feinstein is designed to advance the development of Tivic Health’s ncVNS technology by refining and optimizing stimulation parameters.
Harnessing the Power of the Heart and Mind: Overcoming Atrial Fibrillation and Launching a Business | By Jim Kaveney
Jim Kaveney writes: "In both entrepreneurship and managing AFib, I have learned that the heart and mind are not in opposition but work together in powerful harmony. Whether navigating the unpredictable rhythms of my heart
ACEP to CMS: Require Hospital Plans to Address Boarding in Emergency Departments
ACEP proposes that CMS update its emergency services Condition of Participation (CoP) with a requirement for hospitals to have a plan in place, and to act on it, when the number of patients boarding in
John Beeler Appointed SVP of Business Development at BPGbio
Dr. John Beeler is a seasoned biopharma executive with extensive experience in growing innovative companies, will lead BPGbio’s business development team in securing licensing and commercial partnership opportunities for BPGbio’s NAi Interrogative Biology platform and
Christopher Whitmore Appointed CFO at Ray Therapeutics
Christopher Whitmore is a highly accomplished executive who brings over 20 years of strategic finance, accounting, and operational expertise. His deep experience spans from early-stage biotech to publicly-traded companies, with a focus on both private
Andy Fuller Appointed VP of Market Access at AESAR
With over 27 years of experience in the pharmaceutical industry, Andy Fuller brings extensive expertise in developing and executing go-to-market and payer engagement strategies across highly competitive markets.
Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy
"Receiving both Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 is a significant milestone for Somite Therapeutics and, more importantly, for patients suffering from Duchenne muscular dystrophy," said Dr. Micha Breakstone, Founder and CEO
Circular Genomics Announces Launch of MindLight, the 1st SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
MindLight is the first circular RNA biomarker-based assay designed to predict whether a patient with depression, also known as major depressive disorder, will respond to selective serotonin reuptake inhibitor (SSRI) antidepressant treatment.
EDETEK Announces New Insights on Conducting End-to-End Clinical Trial Solutions
This session, entitled, "Transforming Clinical Trials: From Reactive to Predictive," takes place during the DPHARM Innovative Collaborations Track C, on Tuesday, September 17, 2024, at 4:10pm EDT reports Edetek.
Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings
Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized
Sheba Medical Center to Utilize Sequentify’s InfiniSeq Panel in Study to Detect Clonal Hematopoiesis in Cancer Patients
Sequentify's InfiniSeq technology reduces sample preparation time to just 3.15 hours, from DNA extraction to sequencing, using a single-tube reaction. It supports full automation and significantly reduces costs. The patent-pending InfiniSeq technology is compatible with